Trial intelligence / Profile preview

Peri-operative dopexamine in high-risk major abdominal cancer surgery

2006-002913-11Phase 4Completed

Sponsor
York and Scarborough Teaching Hospitals NHS Foundation Trust
Start
Sep 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in complications of surgical procedures comparing Dopexamine hydrochloride with Placebo / control (2 arms). Primary endpoints: Postoperative morbidity at day 1, Postoperative morbidity at day 3 and 5 more. Started Sep 2006; status: completed.

02

Drugs

dopexamine
03

Conditions

complications of surgical procedures

Beyond the preview

Go deeper on 2006-002913-11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-002913-11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call